The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,355.00
Bid: 2,360.00
Ask: 2,361.00
Change: -16.00 (-0.67%)
Spread: 1.00 (0.042%)
Open: 2,371.00
High: 2,386.00
Low: 2,355.00
Prev. Close: 2,371.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Redemption Closing

5 Nov 2019 10:36

RNS Number : 3105S
BAT International Finance PLC
05 November 2019
 

NOTICE OF REDEMPTION

to the holders of

B.A.T. INTERNATIONAL FINANCE P.L.C.

(the "Issuer")

US$1,250,000,000 2.750% Guaranteed Notes due 2020

(the "Notes")

CUSIP Numbers: G08820 CD5; 05530Q AG5

ISINs: USG08820CD55; US05530QAG55

 

REDEMPTION DATE: 5 November 2019

 

In accordance with Condition 4 (Redemption) of the Notes, the Issuer has redeemed all of its outstanding Notes today, 5 November 2019 (the "Redemption Date"). Citibank, N.A., London Branch acts as fiscal agent, paying agent, transfer agent and registrar under the Notes.

The Redemption Price payment will be made in accordance with Condition 4 (Redemption) of the Notes. The Redemption Price will be equal to US$1,006.24 per US$1,000 principal amount, plus accrued and unpaid interest on the principal amount of the Notes to be redeemed to the Redemption Date, which is equal to US$10.694444 per US$1,000 principal amount.

The Issuer has requested that the Financial Conduct Authority cancel the listing of the Notes, which are listed on the Official List of the Financial Conduct Authority and traded on the Professional Securities Market of the London Stock Exchange plc. This will take effect on or around 7 November 2019.

Unless otherwise defined in this Notice, terms used in this Notice have the meanings given to them in the Notes.

 

For and on behalf of

B.A.T. International Finance p.l.c.

5 November 2019

 

Enquiries:

British American Tobacco Investor Relations Mike Nightingale / Rachael Brierley / John Harney+44 (0) 20 7845 180 / 1519 / 1263

British American Tobacco Press Office +44 (0) 20 7845 2888 (24 hours) | @BATPress

 

Forward looking statements

This announcement contains certain forward-looking statements, including "forward-looking" statements made within the meaning of Section 21E of the United States Securities Exchange Act of 1934. These statements are often, but not always, made through the use of words or phrases such as "believe," "anticipate," "could," "may," "would," "should," "intend," "plan," "potential," "predict," "will," "expect," "estimate," "project," "positioned," "strategy," "outlook", "target" and similar expressions. These include statements regarding our intentions, beliefs or current expectations concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the economic and business circumstances occurring from time to time in the countries and markets in which the British American Tobacco Group (the "Group") operates.

All such forward-looking statements involve estimates and assumptions that are subject to risks, uncertainties and other factors that could cause actual future financial condition, performance and results to differ materially from the plans, goals, expectations and results expressed in the forward-looking statements and other financial and/or statistical data within this announcement. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking statements are uncertainties related to the following: the impact of competition from illicit trade; the impact of adverse domestic or international legislation and regulation; changes in domestic or international tax laws and rates; adverse litigation and dispute outcomes and the effect of such outcomes on the Group's financial condition; changes or differences in domestic or international economic or political conditions; adverse decisions by domestic or international regulatory bodies; the impact of market size reduction and consumer down-trading; translational and transactional foreign exchange rate exposure; the impact of serious injury, illness or death in the workplace; the ability to maintain credit ratings and to fund the business under the current capital structure; the inability to develop, commercialise and roll-out Potentially Reduced-Risk Products; and changes in the market position, businesses, financial condition, results of operations or prospects of the Group.

It is believed that the expectations reflected in this announcement are reasonable but they may be affected by a wide range of variables that could cause actual results to differ materially from those currently anticipated. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on such forward-looking statements.

No statement in this communication is intended to be a profit forecast and no statement in this communication should be interpreted to mean that earnings per share of British American Tobacco p.l.c. ("BAT") for the current or future financial years would necessarily match or exceed the historical published earnings per share of BAT.

Additional information concerning these and other factors can be found in BAT's filings with the U.S. Securities and Exchange Commission ("SEC"), including the Annual Report on Form 20-F filed on 15 March 2019 and Current Reports on Form 6-K, which may be obtained free of charge at the SEC's website, http://www.sec.gov, and BAT's Annual Reports, which may be obtained free of charge from the British American Tobacco website www.bat.com. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFMMGMGKZGLZM
Date   Source Headline
22nd Mar 202410:40 amRNSDirector/PDMR Shareholding
22nd Mar 202410:35 amRNSDirector/PDMR Shareholding
22nd Mar 202410:30 amRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20243:26 pmRNSDirector/PDMR Shareholding
21st Mar 20243:20 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSShare Buy-Back Programme
14th Mar 20248:00 amRNSNotice of AGM
13th Mar 20247:00 amRNSCompletion of Block Trade of ITC Shares
12th Mar 20243:40 pmRNSDirector/PDMR Shareholding
12th Mar 202411:25 amRNSLaunch of Proposed Block Trade of ITC Shares
11th Mar 20244:43 pmRNSResponse to Recent Speculation
11th Mar 20247:00 amRNSBranch Register: Dividend Finalisation Information
7th Mar 20242:20 pmRNSDirector/PDMR Shareholding
5th Mar 20244:30 pmRNSPublication of a Prospectus
4th Mar 20242:15 pmRNSDirector/PDMR Shareholding
1st Mar 202410:45 amRNSDirector/PDMR Shareholding
1st Mar 202410:40 amRNSTotal Voting Rights
21st Feb 202410:45 amRNSDirector/PDMR Shareholding
16th Feb 202411:30 amRNSPricing Notes Offering
15th Feb 20242:55 pmRNSDirector/PDMR Shareholding
13th Feb 20241:30 pmRNSPublication of Suppl.Prospcts
13th Feb 20249:55 amRNSDirector/PDMR Shareholding
9th Feb 20244:17 pmRNSAnnual Financial Report
8th Feb 202412:15 pmRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSFinal Results
6th Feb 202410:10 amRNSDirector/PDMR Shareholding
6th Feb 202410:05 amRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSBoard and Committee Changes
5th Feb 202412:25 pmRNSDirector/PDMR Shareholding
5th Feb 202412:20 pmRNSDirector/PDMR Shareholding
5th Feb 202412:15 pmRNSDirector/PDMR Shareholding
2nd Feb 202412:00 pmRNSBAT and PMI Announce Global Patent Settlement
1st Feb 202412:45 pmRNSTotal Voting Rights
15th Jan 20242:00 pmRNSDirector/PDMR Shareholding
4th Jan 202412:30 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:10 amRNSBlock listing Interim Review
2nd Jan 202410:15 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSBranch Register: Dividend Finalisation Information
11th Dec 202310:35 amRNSHolding(s) in Company
11th Dec 202310:30 amRNSDirector/PDMR Shareholding
7th Dec 20233:30 pmRNSDirector/PDMR Shareholding
7th Dec 20233:30 pmRNSDirector/PDMR Shareholding
6th Dec 20237:55 amRNSPre-Close Trading Update and Strategy Update
6th Dec 20237:00 amRNSPre-Close Trading Update and Strategy Update
4th Dec 202311:30 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.